Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.83 MXN | +0.34% |
|
-3.26% | -17.10% |
| Market Cap | 14.46B 832M 722M 666M 624M 1.17B 79.71B 1.19B 7.94B 3.08B 38.42B 3.12B 3.06B 134B | P/E Ratio 2026 * |
6.42x | P/E Ratio 2027 * | 6.68x |
|---|---|---|---|---|---|
| Enterprise Value | 18.17B 1.05B 907M 836M 784M 1.46B 100B 1.49B 9.98B 3.86B 48.26B 3.92B 3.84B 168B | EV / Sales 2026 * |
0.99x | EV / Sales 2027 * | 0.93x |
| Free-Float |
69.07% | Yield 2026 * |
5.39% | Yield 2027 * | 7.4% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | +0.34% | ||
| 1 week | -3.26% | ||
| Current month | -7.20% | ||
| 1 month | -11.99% | ||
| 3 months | -16.69% | ||
| 6 months | -20.99% | ||
| Current year | -17.10% |
| 1 week | 14.7 |  | 15.34 |
| 1 month | 14.66 | | 16.8 |
| Current year | 14.66 | | 19.48 |
| 1 year | 14.66 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 2023-04-11 |
| Director of Finance/CFO | - | 2015-11-30 | |
| Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1996-10-29 | |
Juan Alonso
BRD | Director/Board Member | - | 2010-07-05 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -3.26% | -31.97% | +1.30% | 832M | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,035B | |
| -0.07% | +4.45% | +53.50% | +48.95% | 574B | |
| -0.08% | -0.08% | +17.37% | +62.66% | 397B | |
| +0.77% | +0.77% | +21.19% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +15.93% | 281B | |
| +2.10% | +4.92% | +25.30% | +34.79% | 278B | |
| -0.19% | -0.46% | -45.32% | -48.23% | 193B | |
| +4.84% | +2.45% | +21.33% | +61.85% | 191B | |
| +3.61% | -2.56% | +15.16% | +61.12% | 156B | |
| Average | +1.43% | +1.60% | +14.46% | +41.46% | 343.08B | |
| Weighted average by Cap. | +1.37% | +2.39% | +29.49% | +72.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.05B 915M 844M 790M 1.48B 101B 1.51B 10.06B 3.9B 48.67B 3.96B 3.87B 169B | 19.24B 1.11B 961M 886M 830M 1.55B 106B 1.58B 10.57B 4.09B 51.1B 4.16B 4.07B 178B |
| Net income | 2.14B 123M 107M 98.37M 92.17M 172M 11.77B 176M 1.17B 454M 5.68B 462M 452M 19.73B | 2.25B 130M 112M 104M 97.1M 181M 12.4B 185M 1.24B 479M 5.98B 486M 476M 20.79B |
| Net Debt | 3.7B 213M 185M 170M 160M 298M 20.41B 305M 2.03B 787M 9.84B 800M 783M 34.2B | 3.44B 198M 172M 158M 148M 277M 18.96B 283M 1.89B 731M 9.14B 743M 727M 31.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 14.83 $ | +0.34% | 3,647,872 |
| 26-06-10 | 14.78 $ | -2.12% | 3,712,730 |
| 26-06-09 | 15.10 $ | +1.14% | 3,854,865 |
| 26-06-08 | 14.93 $ | +1.50% | 4,215,708 |
| 26-06-05 | 14.71 $ | -4.04% | 3,899,161 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
